GeneDx Holdings (WGS) Stock Price, Quote, News & History | Benzinga

GeneDx Holdings Corp (WGS) Stock Price, Quote, News & History

WGSNASDAQ

Trade with Public

Trade with Public

$86.33

-2.91-3.26%

At close: Aug 28, 5:00 PM EST

$87.00

0.670.77%

After Hours: Aug 28, 6:49 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$88.79

Close

$86.34

Volume / Avg.

435.34K / 883.28K

Day Range

$85.93 - $89.74

52 Wk Range

32.21 - 170.87

Market Cap

$2.58B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

40.72%

Days to Cover

6.39

Recent GeneDx Holdings Corp. News

Short Sellers Are All-In on These 10 Stocks — Squeeze Watch List Inside

Ondas, SoundHound AI and CleanSpark are in the top ten most-heavily shorted stocks in the market right now.

Erica Kollmann

Why Is GeneDx Stock Surging Thursday?

GeneDx (WGS) shares rebound 12% as bargain hunters move in following a steep post-earnings sell-off. Is the genetic testing leader oversold?

Akanksha Bakshi

Crude Oil Down 4%; PayPal Shares Fall After Q1 Results

US stocks rise, Nasdaq gains 1%. Dow up 0.57%, Nasdaq up 1.03%, S&P 500 up 0.84%. Materials up 2.1%, financials down 0.2%. PayPal shares fall 9%.

Avi Kapoor

Dow Jumps Over 300 Points; Pfizer Posts Upbeat Earnings

US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.

Avi Kapoor

GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance. Other stocks falling in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-48.71M

Investing Cash Flow (TTM)

-38.64M

Financing Cash Flow (TTM)

73.56M

Free Cash Flow (TTM)

-75.80M

Capital Expenditure (TTM)

-27.09M

Net Change in Cash (TTM)

-13.80M

Analyst Trends and Forecast

1

Mar

1

Apr

4

May

2

Jun

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.61B

PE Ratio (TTM)

-

PE Ratio (FWD)

277.78

PEG Ratio (TTM)

-

PS Ratio (TTM)

5.73

PB Ratio (TTM)

10.89

Earnings Yield % (TTM)

-4.07%

Earnings Yield % (FWD)

0.36%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$8.19

Company Debt

Total Debt

$96.84M

LT Debt

$96.84M

LT Debt Issuance (TTM)

$96.70M

LT Debt Repayment (TTM)

-$61.33M

Total Cash

$60.32M

Debt to Equity

0.69

Issuance of Debt (TTM)

$35.37M

Repayment of Debt (TTM)

-$61.33M

Key Statistics

Open

$88.79

Close

$86.34

Volume / Avg.

435.34K / 883.28K

Day Range

$85.93 - $89.74

52 Wk Range

32.21 - 170.87

Market Cap

$2.58B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

40.72%

Days to Cover

6.39

About

Sector

Health Care

Industry

Health Care Providers & Services

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy GeneDx Holdings (WGS) stock?

A

You can purchase shares of GeneDx Holdings (NASDAQ:WGS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are GeneDx Holdings (WGS) competitors?

A

Other companies in GeneDx Holdings’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).

Q

What is the forecast, or price target, for GeneDx Holdings (WGS) stock?

A

GeneDx Holdings has a consensus price target of $87.50.

Q

What is the current price for GeneDx Holdings (WGS)?

A

The stock price for GeneDx Holdings (NASDAQ: WGS) is $87 last updated August 28, 2026 at 6:49 PM EDT.

Q

Does GeneDx Holdings (WGS) pay a dividend?

A

There are no upcoming dividends for GeneDx Holdings.

Q

When is GeneDx Holdings (NASDAQ:WGS) reporting earnings?

A

GeneDx Holdings does not have any upcoming earnings scheduled.

Q

Is GeneDx Holdings (WGS) going to split?

A

There is no upcoming split for GeneDx Holdings.

Q

What sector and industry does GeneDx Holdings (WGS) operate in?

A

GeneDx Holdings is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.